Douglas V. Guzior
- Biological Psychiatry top 10%
- Gastroenterology top 10%
-
- Gut microbiota and health 9
- Metabolomics and Mass Spectrometry Studies 2
-
- Drug Transport and Resistance Mechanisms 4
-
- Cystic Fibrosis Research Advances 4
-
- Pediatric health and respiratory diseases 2
-
- Clostridium difficile and Clostridium perfringens research 2
-
- Probiotics and Fermented Foods 2
-
- Pediatric Hepatobiliary Diseases and Treatments 2
- Co-authors
- Robert A. QuinnChristian MartinKerri A. NeugebauerMatthew J. PestrakAlexander R. HorswillAnthony L. SchilmillerYousi FuC. R. Bridges
- Partner nations
- United StatesAustriaFrance
In The Last Decade
Douglas V. Guzior
13 papers receiving 716 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Biological Psychiatry 32
- Gastroenterology 43
- Molecular Biology 448
- Oncology 176
- Physiology 160
Countries citing papers authored by Douglas V. Guzior
This map shows the geographic impact of Douglas V. Guzior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas V. Guzior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas V. Guzior more than expected).
Fields of papers citing papers by Douglas V. Guzior
This network shows the impact of papers produced by Douglas V. Guzior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas V. Guzior. The network helps show where Douglas V. Guzior may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas V. Guzior, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 0 | |
| 3 | Bile salt hydrolase acyltransferase activity expands bile acid diversitybreakdown → | 2024 | 80 |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 1 | |
| 12 | Review: microbial transformations of human bile acidsbreakdown → | 2021 | 475 |
| 13 | 2021 | 44 | |
| 14 | 2020 | 51 |
About Douglas V. Guzior
Douglas V. Guzior is a scholar working on Emergency Medical Services, Molecular Biology and Clinical Biochemistry, having authored 14 papers that have together received 723 indexed citations. Recurring topics across this work include Gut microbiota and health (9 papers), Drug Transport and Resistance Mechanisms (4 papers), Cystic Fibrosis Research Advances (4 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Pediatric health and respiratory diseases (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Probiotics and Fermented Foods (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). The work is most often cited by research in Biological Psychiatry (32 citations), Gastroenterology (43 citations) and Molecular Biology (448 citations). Douglas V. Guzior has collaborated with scholars based in United States, Austria and France. Frequent co-authors include Robert A. Quinn, Christian Martin, Kerri A. Neugebauer, Matthew J. Pestrak, Alexander R. Horswill, Anthony L. Schilmiller, Yousi Fu, C. R. Bridges, Devendra H. Dusane and Paul Stoodley. Their work appears in journals such as Nature, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.